Advertisement

Topics

Study to Test an Approved Product in the Early Treatment of Migraine

2014-08-27 03:54:00 | BioPortfolio

Summary

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Conditions

Migraine

Intervention

MK0462, rizatriptan benzoate / Duration of Treatment: 1day, Comparator: placebo / Duration of Treatment: 1 day

Status

Completed

Source

Merck

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:54:00-0400

Clinical Trials [946 Associated Clinical Trials listed on BioPortfolio]

MK0462 in Treatment of Migraine With Recurrence

A study to evaluate rizatriptan/MK0462(5 and 10 mg) for the treatment of acute migraine attack and treatment of up to two headache recurrences compared to placebo.

MK0462 5 mg, Sumatriptan 50 mg, and Placebo Comparison Study

A study to compare rizatriptan (MK0462) 5 mg p.o. (by mouth) and sumatriptan 50 mg p.o. for the acute treatment of a migraine attack.

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine

The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.

Study to Test an Approved Product in the Early Treatment of Migraine

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine.

Study to Test a Marketed Drug in the Treatment of Menstrual Migraine

The purpose of this study is to test the effectiveness of a marketed drug in the treatment of a menstrual migraine attack.

PubMed Articles [18086 Associated PubMed Articles listed on BioPortfolio]

Placebo Effects in the Treatment of Noncognitive Symptoms of Alzheimer's Disease: Analysis of the CATIE-AD Data.

To compare symptom trajectories between placebo and active drug responders and to examine whether early placebo improvement would be associated with subsequent placebo response in the treatment of pat...

Magnitude and pattern of placebo response in clinical trials of antiepileptic medications: Data from the Food and Drug Administration 1996-2016.

This study aimed to replicate and extend the findings of previous investigations looking at treatment responses in antiepileptic clinical trials over time and to examine the effects of subject age and...

Statin add-on therapy in the antipsychotic treatment of schizophrenia: A meta-analysis.

A comprehensive meta-analysis of statin add-on therapy in the antipsychotic treatment of schizophrenia was conducted. Data from previous studies, prior to 8/21/2017, was obtained from Scopus, PubMed, ...

Fremanezumab for the Preventive Treatment of Chronic Migraine.

Background Fremanezumab, a humanized monoclonal antibody targeting calcitonin gene-related peptide (CGRP), is being investigated as a preventive treatment for migraine. We compared two fremanezumab do...

No evidence for an acute placebo effect on emotional processing in healthy volunteers.

Placebo-controlled trials are the gold standard measure of efficacy in the development of new treatments for depression. However, the large placebo effects associated with standard measures of subject...

Medical and Biotech [MESH] Definitions

An enzyme that catalyzes the oxidation of BENZOATE to 4-hydroxybenzoate. It requires IRON and tetrahydropteridine.

Misunderstanding among individuals, frequently research subjects, of scientific methods such as randomization and placebo controls.

A narcotic analgesic with a long onset and duration of action. It is used mainly in the treatment of narcotic dependence.

An ADRENERGIC BETA-2 RECEPTOR AGONIST with a prolonged duration of action. It is used to manage ASTHMA and in the treatment of CHRONIC OBSTRUCTIVE PULMONARY DISEASE.

A cholinesterase inhibitor with a slightly longer duration of action than NEOSTIGMINE. It is used in the treatment of myasthenia gravis and to reverse the actions of muscle relaxants.

More From BioPortfolio on "Study to Test an Approved Product in the Early Treatment of Migraine"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Anesthesiology
An anesthesiologist (US English) or anaesthetist (British English) is a physician trained in anesthesia and perioperative medicine. Anesthesiologists are physicians who provide medical care to patients in a wide variety of (usually acute) situations. ...


Searches Linking to this Trial